Omnicell (OMCL) Tops Q1 EPS by 13c, Revenues Beat

Omnicell (NASDAQ: OMCL) reported Q1 EPS of $0.66, $0.13 better than the analyst estimate of $0.53. Revenue for the quarter came in at $229.7 million versus the consensus estimate of $219.41 million.

“Our mission to be a trusted partner for our customers has never been more critical,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. “Our teams have mobilized to quickly deliver the solutions and intelligence needed to support critical care needs, while protecting the health and safety of our customers and employees, and maintaining business continuity.”

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Wells Fargo plans 11% dividend increase after completing stress test
• Qualcomm targets $40B in non-handset revenue by fiscal 2029